Maharashtra

CBI Files Bank Fraud Case Against Hanjer Biotech in Maharashtra

The Central Bureau of Investigation (CBI) has initiated a bank fraud case against Hanjer Biotech, a prominent company in Maharashtra, following allegations of financial misconduct. The case revolves around misappropriation of funds involving ₹100 crore. The agency is set to scrutinize the company's financial records and transactions. This investigation highlights increasing scrutiny on corporate governance in Maharashtra, as authorities crack down on financial irregularities. Stakeholders are concerned about the implications for business operations in the region.

Rajesh Singh

Rajesh Singh

Oct 3, 2026

22 views

This article was curated with AI assistance and published by the MBN News Desk.

CBI Files Bank Fraud Case Against Hanjer Biotech in Maharashtra
AI Generated ImageSource: MBN News Desk

Key Takeaways

  • •CBI registers case against Hanjer Biotech for fraud
  • •Allegations involve misappropriation of ₹100 crore
  • •Investigation highlights corporate governance issues

The Central Bureau of Investigation (CBI) has officially registered a bank fraud case against Hanjer Biotech, a significant player in the biotechnology sector based in Maharashtra. This action comes after allegations surfaced regarding the misappropriation of funds amounting to approximately ₹100 crore. The investigation aims to uncover the extent of the financial discrepancies and the involvement of any other parties.

According to sources, the allegations suggest that Hanjer Biotech may have engaged in fraudulent practices that misled banking institutions. This follows a series of complaints from various stakeholders who expressed concerns over the company’s financial management. The CBI is expected to conduct a thorough examination of the company's financial records, including bank statements, transaction histories, and related documents to substantiate the claims.

  • Allegations of Misappropriation — The CBI is investigating claims that funds were diverted for unauthorized purposes.
  • Impact on Corporate Governance — This case underscores the growing scrutiny on corporate practices in Maharashtra.
  • Potential Legal Consequences — If proven guilty, the involved parties may face serious legal repercussions.

This case is part of a broader effort by Indian authorities to enhance corporate governance and accountability within the business sector. The increasing number of fraud investigations reflects a shift towards stricter enforcement of financial regulations. Business leaders in Maharashtra are expressing concern over how these developments might affect investor confidence and the overall business climate in the region.

As the investigation progresses, stakeholders are closely monitoring the situation, particularly given the potential ramifications for the biotechnology industry. Hanjer Biotech has yet to publicly respond to the allegations, leaving many to speculate about the company’s future operations and reputation. The outcome of this case could set a precedent for how financial fraud cases are handled in Maharashtra moving forward.

Source: MBN News Desk
#CBI#Hanjer Biotech#Maharashtra#bank fraud#financial irregularities#corporate governance#biotechnology#investment#legal consequences#Thane

Related Articles